Induction of hypothyroxinemia adjunct therapy

· Musli Thyropeutics Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Induction of hypothyroxinemia adjunct therapy, covering 2018-03-22 to 2018-03-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients [Phase 2]